E-LIB Suche - Ergebnisse für: Miklós, T.

1

PB1210 Incorporation of a2-Plasmin Inhibitor into Plasma Cl..:

Katona, É. ; Baráth, B. ; Gindele, R...
Research and Practice in Thrombosis and Haemostasis. 7 (2023) - p. 101033 , 2023

Link: https://doi.org/10.1016/..

2

C0290: Diagnostic Considerations Based on the Experience of..:

Miklós, T. ; Oláh, Z. ; Schlammadinger, Á....
Thrombosis Research. 133 (2014) - p. S81 , 2014

Link: https://doi.org/10.1016/..

3

Footprint-adjusted net ecosystem CO2 exchange and carbon ba..:

Nagy, Miklos T. ; Janssens, Ivan A. ; Curiel Yuste, Jorge..
Agricultural and Forest Meteorology. 139 (2006) 3-4 - p. 344-360 , 2006

Link: https://doi.org/10.1016/..

4

Novel Feedback Controlled Circular Water Warming System (Al..:

Katz, Jacob ; Steinberg, Ran ; Kachko, Ludmyla..
Anesthesiology. 96 (2002) Sup 2 - p. A591 , 2002

Link: https://doi.org/10.1097/..

5

Computer simulation for the design of high performance, hig..:

Rizkalla, Maher E. ; Kara, Miklos T.
Solid State Communications. 88 (1993) 8 - p. 609-612 , 1993

Link: https://doi.org/10.1016/..

6

Bendamustine is a safe and effective lymphodepletion agent ..:

Bharadwaj, Sushma ; Lau, Eric ; Hamilton, Mark P...
Journal for ImmunoTherapy of Cancer. 12 (2024) 7 - p. e008975 , 2024

Link: https://doi.org/10.1136/..

7

Bridging therapy with axicabtagene ciloleucel for large B-c..:

Jain, Michael D. ; Jacobs, Miriam T. ; Gao, Feng...
Blood Advances. 8 (2024) 4 - p. 1042-1050 , 2024

Link: https://doi.org/10.1182/..

8

Optimal timing of of cardiac implantable electronic device ..:

Schvartz, N ; Haidary, A ; Operhalski, F...
Europace. 26 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

9

PRIMARY OVERALL SURVIVAL ANALYSIS OF THE PHASE 3 RANDOMIZED..:

Westin, J. R. ; Oluwole, O. O. ; Kersten, M. J....
Hematological Oncology. 41 (2023) S2 - p. 52-54 , 2023

Link: https://doi.org/10.1002/..

10

BISPECIFIC ANTI‐CD20/19 CAR‐T—ZAMTOCABTAGENE AUTOLEUCEL FOR..:

Ulrickson, M. ; Miklos, D. B. ; Maziarz, R. T...
Hematological Oncology. 41 (2023) S2 - p. 147-147 , 2023

Link: https://doi.org/10.1002/..

11

P1117: THREE-YEAR FOLLOW-UP OF OUTCOMES WITH KTE-X19 IN PAT..:

Wang, M. L. ; Munoz, J. ; Goy, A....
HemaSphere. 6 (2022) - p. 1007-1008 , 2022

Link: https://doi.org/10.1097/..

12

List of contributors:

, In: New Aspects of Meat Quality,

Aalhus, J.L. ; Bertram, Hanne Christine ; Bjørge Müller, Mette Helen... - p. xi-xiv , 2022

Link: https://doi.org/10.1016/..

13

S211: CLINICAL AND PATIENT-REPORTED OUTCOMES IN A PHASE 3 S..:

Sureda, A. ; Westin, J. ; Locke, F. L....
HemaSphere. 6 (2022) - p. 112-113 , 2022

Link: https://doi.org/10.1097/..

14

A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adu..:

Andermann, Tessa M. ; Fouladi, Farnaz ; Tamburini, Fiona B....
Transplantation and Cellular Therapy. 27 (2021) 11 - p. 932.e1-932.e11 , 2021

Link: https://doi.org/10.1016/..

15

Recurrent acute pancreatitis prevention by the elimination ..:

Ocskay, K. ; Juhász, M.F. ; Farkas, N....
Pancreatology. 21 (2021) - p. S28-S29 , 2021

Link: https://doi.org/10.1016/..